Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway
Simona Volpi(National Institutes of Health), Greti Aguilera(National Institutes of Health)
Cited by 15
Related Papers
Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems
|Clinical Pharmacology & Therapeutics|2014|246
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
|Clinical Pharmacology & Therapeutics|2016|189
Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor
|Biochemical and Biophysical Research Communications|1983|170